Optimizing Frequency of CD4 Assays in the Era of Highly Active Antiretroviral Therapy
Aditya H. Gaur(St. Jude Children's Research Hospital), Hua Liang(Sun Yat-sen University), Patricia M. Flynn(St. Jude Children's Research Hospital), Wally Bitar(St. Jude Children's Research Hospital)
Cited by 1
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs
|Nature Medicine|1999|580
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
|New England Journal of Medicine|2016|348